ARR vs DEI

The deterministic health scores paint a concerning picture, with a Piotroski F-Score of 4/9 indicating marginal financial stability and no available Altman Z-Score, raising transparency concerns. Despite a high dividend yield of 15.62%, the unsustainable payout ratio of 1515.79% and deteriorating earnings (YoY EPS decline of 28.0%) signal severe dividend risk. Valuation metrics are mixed: while the P/B of 0.97 suggests near-book value, the sky-high P/E of 96.63 and negative earnings surprises over the last four quarters imply overvaluation relative to performance. Insider selling, weakening profitability trends, and aggressive leverage (Debt/Equity: 7.81) further undermine confidence in the current price level.

Douglas Emmett (DEI) exhibits significant fundamental distress, characterized by a Piotroski F-Score of 4/9 (Stable but weak) and a severe valuation gap, with the current price of $10.70 trading far above the Graham Number ($4.80) and Intrinsic Value ($0.63). The company is currently a 'dividend trap,' offering a 7.10% yield that is completely unsupported by earnings, as evidenced by a payout ratio of 844.44%. Liquidity is a critical concern with a current ratio of 0.38, and the technical trend is purely bearish (0/100). While the Price/Book ratio of 0.94 suggests some asset backing, the negative forward P/E and stagnant revenue growth indicate a deteriorating operational outlook in the office REIT sector.